I'm LongbridgeAI, I can summarize articles.Amgen Inc. (AMGN) shares fell 1.79% to $439.26 on Friday, underperforming compared to competitors like Johnson & Johnson and Pfizer during a broader market decline. The stock closed 2.60% below its 52-week high of $450.98. Trading volume was notably lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. (AMGN) slipped 1.79% to $439.26 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.52% to 7,623.68 and Dow Jones Industrial Average falling 1.23% to 52,215.16.
Amgen Inc. closed 2.60% short of its 52-week high of $450.98, which the company reached on October 22nd.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) fell 1.42% to $263.81, Pfizer Inc. (PFE) fell 1.28% to $30.03, and AbbVie Inc. (ABBV) rose 0.16% to $285.64.
Trading volume (1.7 M) remained 1.1 million below its 50-day average volume of 2.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 23, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
10-23-26 1634ET